Blossomhill Therapeutics Inc <BLSM.O>: H.C. Wainwright initiates coverage with buy rating; target price $35
BLSM•Related News
Pound slips despite jump in gilt yields as investors favour dollar
TLT•
Global bond rout deepens as Japan yield hits key milestone
TLT•
Ingram Micro Holding Corporation: Deutsche Bank initiates coverage with hold rating and target price $30
INGM•
Calumet targets 200 million gallons of SAF output at Montana Renewables by end-2028 with USD 137 million expansion plan
CLMT•
BeyondSpring highlights confirmatory Phase 3 DUBLIN-4 trial plan for plinabulin in post-ICI NSCLC
BYSI•